Astex Pharmaceuticals announced today that it will make five key data presentations at the 36th EORTC-NCI-AACR Symposium on molecular targets and cancer therapeutics, 23rd-25th October 2024, Barcelona, Spain.
Attending the BIA’s TechBio UK conference this year offered an incredible opportunity to witness the ingenuity and innovation driving the future of life sciences.
This is part of a series of blogs focussing on hearing therapeutics from different sector perspectives. In this blog, Karen Steel shares her thoughts on what she perceives to be some of the biggest opportunities in relation to the development of new treatments for hearing loss.
The UK is a global leader in TechBio, drawing substantial investments and nurturing a vibrant ecosystem of talent and businesses, reveals a report launched today by the BIA.
Read the BIA's 2024 TechBio report to learn the current state of the sector and to read case studies from companies on the vanguard of innovation within the field.
Pioneer Group welcomed 425 school children from 29 schools to eight of its sites across the UK this week to mark Ada Lovelace Day, an international celebration of the achievements of women in STEM.
Today marks a pivotal moment for our Association as a key strategic objective has been realised: the new government has placed growth at the centre of its agenda, with life sciences positioned as a cornerstone of that plan.
In this insightful blog, Louis Taylor, CEO of the British Business Bank, explores how the Mansion House reforms and increased pension fund investments could unlock billions in domestic capital, fueling the next generation of UK innovators.
The BIA’s policy and public affairs team attended the conferences of the three major UK parties this year. This is a key point in the political calendar and allows us to highlight the sector through fringe events, meet policymakers, and get a sense of the political environment.
Ingenza, a world-leading contract research, development and manufacturing organisation (CRDMO) and technology accelerator, has signed a 10-year lease at the Moubray Building at Edinburgh Technopole, part of Pioneer Group.
Dr Peter Bloomfield is the Director of Research at the Macular Society. In this guest blog, he lays out the problem posed by macular disease and his hope for a solution. He also gives insight into why the Macular Society joined the BIA.
London, October 3, 2024 – Coulter Partners recently partnered with MTIP and the Nitinotes Board to conduct a successful search for a new Chief Executive Officer (“CEO”) for Nitinotes.
Cancer Research UK and NovalGen have signed an agreement to bring NovalGen’s next-generation T-cell engager, NVG-222, into a first-in-human clinical trial.